Alnylam Pharmaceuticals
ALNY
#447
Rank
A$78.63 B
Marketcap
A$595.22
Share price
-2.21%
Change (1 day)
53.63%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company